FTC has Ended the Obligation of Roche Holding Ltd. to Obtain Prior-Approval to Acquire an Interest Greater than One Percent in any Company Involved in the Market for Drug Abuse Testing (DAT) Products, and the Markets for Vitamin C, Human Growth Factor,